A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

Teva Pharmaceutical Industries Ltd. ADR 0.29% $19.16B ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Vaccine makers face a demand cliff as coronavirus vaccines wane, but these stocks are more than meets the eye.

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 40,857.35 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

"This approval reflects our ambition to protect people at increased risk from the severe consequences of RSV infection," said GSK's chief scientific officer Tony Wood. "Adults aged 50-59 with ...

After hours: November 21 at 6:50 p.m. EST ...

After hours: 22 November at 19:18 GMT-5 ...